Analysis of NeuroEyeCoach data

NeuroEyeCoach (NEC) is a rehabilitation intervention programme aimed at those with visual field defects as a result of brain trauma, stroke, other insults or surgical procedures. It alleviates the disability associated with visual field defect by improving the patient’s visual scanning technique. Smaller studies using similar stimulus configurations have shown success of eye-movement therapy on visual search performance metrics, such as shorter search times and less detection errors (Zihl 1985; Meienberg et al., 1981; Zihl & Hebel 1997). To evaluate the effect of rehabilitation on patient’s activities of daily life, a questionnaire is often used where the patient self-reports their experience of disability on 10 aspects of daily life on a 5 point Likert-scale (Nelles et al 2001). NEC therefore includes visual search tasks and a disability questionnaire pre and post intervention to evaluate outcome. NEC is delivered through an online programme, adaptive to the patient’s visual disability and self-administered at home or in a clinical setting (Sahraie et al., 2016). NEC was developed by NovaVision Inc. (Boca Raton, Florida), is registered with the FDA as 510(k) exempt medical device in the US and CE registered as Type I Medical Device in the EU; and. Over 200 participants have completed NEC to-date.

神经视觉教练（NEC）是一项旨在针对因脑损伤、中风、其他损伤或手术而导致的视野缺损患者的康复干预项目。该项目通过改善患者的视觉扫描技术，缓解与视野缺损相关的功能障碍。采用类似刺激配置的小型研究表明，眼动疗法在视觉搜索性能指标上取得了成功，例如缩短搜索时间和减少检测错误（Zihl 1985；Meienberg 等人，1981；Zihl 和 Hebel 1997）。为了评估康复对患者日常生活活动的影响，通常使用问卷，患者自行报告其在日常生活10个方面的残疾体验，采用5点李克特量表（Nelles 等人，2001）。因此，NEC包括视觉搜索任务和残疾问卷，以评估干预前后的结果。NEC通过在线程序提供，适应患者的视觉障碍，并可在家中或临床环境中自行管理（Sahraie 等人，2016）。NEC由 NovaVision Inc.（佛罗里达州博卡拉顿）开发，在美国获得FDA 510(k) 免检医疗设备的注册，并在欧盟获得 CE 认证为第一类医疗器械；并且，截至目前已有超过200名参与者完成了NEC。